norethindrone has been researched along with Osteogenic Sarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baylink, DJ; Demarest, KT; Lau, KH; Linkhart, TA; Wang, SP | 1 |
Baylink, DJ; Lau, KH; Takada, J | 1 |
2 other study(ies) available for norethindrone and Osteogenic Sarcoma
Article | Year |
---|---|
Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption.
Topics: Animals; Bone and Bones; Bone Development; Bone Resorption; Calcitriol; Cell Differentiation; Cell Division; Chickens; Collagen; DNA; Humans; Mice; Norethindrone; Organ Culture Techniques; Osteoblasts; Osteocalcin; Osteosarcoma; Thymidine; Tumor Cells, Cultured | 1994 |
Pretreatment with low doses of norethindrone potentiates the osteogenic effects of fluoride on human osteosarcoma cells.
Topics: Alkaline Phosphatase; Androgens; Bone Neoplasms; Calcitriol; Collagen; Dose-Response Relationship, Drug; Drug Synergism; Fluorides; Humans; Norethindrone; Osteocalcin; Osteogenesis; Osteosarcoma; Progestins; Thymidine; Tumor Cells, Cultured | 1995 |